NAS:TMDX (USA)
TransMedics Group Inc $ 36.88 -1.58 (-4.11%)
Volume:
1,204,965
Avg Vol (1m):
607,241
Market Cap $:
1.00 Bil
Enterprise Value $:
903.50 Mil
PE Ratio:
0.00
PB Ratio:
9.14
Current and historical daily P/E ratio for TMDX (TransMedics Group Inc) from 2019 to Feb 25 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. TransMedics Group stock (TMDX) PE ratio as of Feb 25 2021 is 0.
More Details
TransMedics Group PE Ratio (TTM) Chart
EMBED
TransMedics Group PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Total 460
- 1
- 2
- 3
- 4
- 5
- 6
| TransMedics Group PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2021-02-25 | 0.0 | 2020-12-21 | 0.0 |
| 2021-02-24 | 0.0 | 2020-12-18 | 0.0 |
| 2021-02-23 | 0.0 | 2020-12-17 | 0.0 |
| 2021-02-22 | 0.0 | 2020-12-16 | 0.0 |
| 2021-02-19 | 0.0 | 2020-12-15 | 0.0 |
| 2021-02-18 | 0.0 | 2020-12-14 | 0.0 |
| 2021-02-17 | 0.0 | 2020-12-11 | 0.0 |
| 2021-02-16 | 0.0 | 2020-12-10 | 0.0 |
| 2021-02-15 | 0.0 | 2020-12-09 | 0.0 |
| 2021-02-12 | 0.0 | 2020-12-08 | 0.0 |
| 2021-02-11 | 0.0 | 2020-12-07 | 0.0 |
| 2021-02-10 | 0.0 | 2020-12-04 | 0.0 |
| 2021-02-09 | 0.0 | 2020-12-03 | 0.0 |
| 2021-02-08 | 0.0 | 2020-12-02 | 0.0 |
| 2021-02-05 | 0.0 | 2020-12-01 | 0.0 |
| 2021-02-04 | 0.0 | 2020-11-30 | 0.0 |
| 2021-02-03 | 0.0 | 2020-11-27 | 0.0 |
| 2021-02-02 | 0.0 | 2020-11-25 | 0.0 |
| 2021-02-01 | 0.0 | 2020-11-24 | 0.0 |
| 2021-01-29 | 0.0 | 2020-11-23 | 0.0 |
| 2021-01-28 | 0.0 | 2020-11-20 | 0.0 |
| 2021-01-27 | 0.0 | 2020-11-19 | 0.0 |
| 2021-01-26 | 0.0 | 2020-11-18 | 0.0 |
| 2021-01-25 | 0.0 | 2020-11-17 | 0.0 |
| 2021-01-22 | 0.0 | 2020-11-16 | 0.0 |
| 2021-01-21 | 0.0 | 2020-11-13 | 0.0 |
| 2021-01-20 | 0.0 | 2020-11-12 | 0.0 |
| 2021-01-19 | 0.0 | 2020-11-11 | 0.0 |
| 2021-01-15 | 0.0 | 2020-11-10 | 0.0 |
| 2021-01-14 | 0.0 | 2020-11-09 | 0.0 |
| 2021-01-13 | 0.0 | 2020-11-06 | 0.0 |
| 2021-01-12 | 0.0 | 2020-11-05 | 0.0 |
| 2021-01-11 | 0.0 | 2020-11-04 | 0.0 |
| 2021-01-08 | 0.0 | 2020-11-03 | 0.0 |
| 2021-01-07 | 0.0 | 2020-11-02 | 0.0 |
| 2021-01-06 | 0.0 | 2020-10-30 | 0.0 |
| 2021-01-05 | 0.0 | 2020-10-29 | 0.0 |
| 2021-01-04 | 0.0 | 2020-10-28 | 0.0 |
| 2020-12-31 | 0.0 | 2020-10-27 | 0.0 |
| 2020-12-30 | 0.0 | 2020-10-26 | 0.0 |
| 2020-12-29 | 0.0 | 2020-10-23 | 0.0 |
| 2020-12-28 | 0.0 | 2020-10-22 | 0.0 |
| 2020-12-24 | 0.0 | 2020-10-21 | 0.0 |
| 2020-12-23 | 0.0 | 2020-10-20 | 0.0 |
| 2020-12-22 | 0.0 | 2020-10-19 | 0.0 |
TransMedics Group PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Compare
NAS:AXGN
NAS:CTSO
NAS:XENT
NAS:SPNE
NAS:ATEC
NAS:ESTA
NAS:BSGM
NAS:IRMD
OTCPK:SMLR
NAS:VRAY
NYSE:ABT
NYSE:MDT
NYSE:SYK
NYSE:BSX
SZSE:300760
NYSE:EW
NYSE:ZBH
NAS:ALGN
LSE:SN.
NYSE:BIO
Traded in other countries
TMDX.USA
Address
200 Minuteman Road, Andover, MA, USA, 01810
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.